Khosla Ventures

Khosla Ventures is a California-based venture capital firm founded in 2004 by Vinod Khosla. It provides capital and strategic guidance to startups across stages, focusing on technology-driven companies in areas such as artificial intelligence, climate and sustainability, enterprise software and services, fintech, digital health, medical technology and diagnostics, therapeutics, consumer products, and frontier technologies. The firm backs bold ventures with the potential to disrupt markets and improve lives, supporting companies from early to growth stages and working closely with entrepreneurs to apply science, technology and innovative business models. While primarily investing in North American technology companies, Khosla Ventures pursues opportunities globally and emphasizes experimentation and impact alongside financial returns. The firm also maintains related impact initiatives that support entrepreneurs addressing socio-economic challenges in emerging markets.

Alex Bentley

Partner and Investor

Ryno Blignaut

Operating Partner

Alice Brooks

Partner

Peter Buckland JD

COO, Partner, and Managing Director

Brian Byun

Venture Partner

Catherine Casuga

Operating Partner

Jon Chu

Partner

Adam Coates Ph.D

Operating Partner

Ardy Daie

Operating Partner

Bryan Gartner

Partner

Kanu Gulati

Partner

Kanupriya Gulati Ph.D

Partner and Investor

Judy Huang

Operating Partner

Jun Jeon

Principal

Samir Kaul

Founding General Partner

Vinod Khosla

Managing Director

Kelly Kinnard

Operating Partner

Alex Morgan

Partner

Nabeel Quryshi

Associate

Arash Rebek JD

Partner, Capital Formation

Jessy Rivest

Partner

Jai Sajnani

Partner

Leah Scanlan

Operating Partner

Nikita Shamgunov

Partner

Sven Strohband

Managing Director

Rajesh Swaminathan

Partner and Investor

Adina Tecklu

Partner

David Weiden

Partner

Reze Wong

Partner

Ece Erdagoz Wyrick

Principal

Past deals in Early Venture Stage

Industrial Next

Series A in 2025
Industrial Next specializes in developing advanced automation technologies for flexible and intelligent manufacturing. Their core focus is on creating intelligent vision systems, combining hardware and software to enhance production processes.

ExaForce

Series A in 2025
ExaForce develops a cloud security platform that helps security teams manage cloud risk for fast-growing companies, providing real-time visibility into security posture, risk assessment, and incident response to detect and remediate threats and strengthen cloud infrastructure.

Loti

Series A in 2025
Loti is an innovative identity management solution that safeguards individuals' online identities using advanced facial recognition technology. It proactively detects and manages instances of unauthorized use of someone's face, deep fakes, adult content, and other privacy infringements across the internet. Loti empowers users to control their digital identity by streamlining the process of monitoring, reporting, and issuing DMCA takedown notices.

Roam

Series A in 2025
Roam is the platform for affordable home ownership. Roam helps homebuyers purchase their next home with a low-interest rate mortgage included.

Spiritus

Series A in 2025
Spiritus is a climate technology company specializing in direct-air-capture systems. Its innovative approach combines the Spiritus Sorbent and Carbon Orchard, offering a scalable, modular solution for low-cost carbon dioxide removal and sequestration.

Atomicwork

Series A in 2025
Founded in 2022, Atomicwork is a San Francisco-based company specializing in modern service management software. Its platform integrates with popular tools like Microsoft Teams and Slack, enabling employees to resolve IT issues directly from these platforms without needing to access separate portals.

Basis

Series A in 2024
Basis develops AI agents that assist accountants by automating accounting workflows. The agents integrate with existing systems and adapt to the needs of each engagement. The company serves industries such as finance and accounting.

Physical Intelligence

Series A in 2024
Physical Intelligence is a technology company specializing in integrating artificial intelligence with robotics and physical devices. It develops foundational models and learning algorithms to enable robots and other physical devices to perform a wide range of tasks across various industries.

RedoxBlox

Series A in 2024
RedoxBlox develops thermochemical energy storage technology to decarbonize high-temperature industrial thermal processing and provide long-duration energy storage for the grid. The technology enables continuous high-temperature heat while integrating with existing infrastructure to replace natural gas combustion, supporting electrification and renewables deployment. It reduces carbon dioxide and nitrogen oxides emissions, enhances safety and resilience, and aims to lower total capital cost for industrial processors and power plant operators. By delivering scalable, long-duration heat, RedoxBlox helps industries leverage renewable energy and move toward low-emission operations.

Even

Series A in 2024
Even partners with top hospitals nationwide to offer unlimited diagnostics, consultations, and hospitalization coverage worth INR 50 lakhs via a single monthly subscription.

Genie AI

Series A in 2024
Genie AI is a London-based legal tech company offering an AI-powered platform for drafting contracts. Its product SuperDrafter leverages the knowledge of a law firm to accelerate drafting, while Anonymiser redacts sensitive information. The platform understands contracts semantically and supports smart contract development. Genie AI also provides educational talks and practical training on smart contracts to improve risk management and efficiency. Founded in 2017, the company serves law firms seeking faster, more accurate contract workflows and exploration of smart contract adoption.

Rogo

Series A in 2024
Rogo is the secure, state-of-the-art Generative AI platform purpose-built for elite financial institutions. Trusted by thousands of investment bankers, asset managers, and private equity professionals, Rogo streamlines workflows, rapidly unlocks strategic insights, and saves valuable time—all within the industry's most rigorous security standards. Empower your team to analyze, automate, and innovate with confidence

Enzymit

Series A in 2024
Enzymit is a biotechnology company focused on revolutionizing global manufacturing through sustainable and efficient bio-production methods. It specializes in developing cell-free bio-production technology that aims to eliminate the inefficiencies and complexities associated with traditional bio-production. Enzymit employs artificial intelligence and deep learning algorithms to design novel enzymes, which serve as molecular machines capable of transforming abundant feedstocks into valuable products, including pharmaceuticals, cosmetics, food, and materials. The company’s small, modular bio-reactors facilitate this process, promoting resource independence while minimizing environmental impact. By moving away from conventional whole-cell methods to utilizing nature's elemental building blocks, Enzymit enhances cost-effectiveness, efficiency, and sustainability in bio-production, while also providing greater flexibility in product customization for various industries.

Distyl AI

Series A in 2024
Distyl AI collaborates with organizations worldwide to enhance their artificial intelligence readiness. It develops integrated AI-based solutions tailored to clients' unique data, workflows, and employee requirements, enabling seamless integration with existing technologies.

Synex Medical

Series A in 2024
Synex Medical is a company focused on advancing health monitoring technology through non-invasive blood testing. It has developed a portable device that utilizes a miniaturized magnetic resonance system to measure blood metabolites without the need for skin penetration. This innovative approach employs only magnets and radio waves, ensuring no adverse health effects for users. By accurately measuring critical metabolites such as glucose, lactate, and ketones, Synex Medical's technology empowers individuals to monitor their health proactively and make informed decisions about their well-being.

Noetik

Series A in 2024
Noetik is an AI-native biotechnology company focused on the discovery and development of cancer immunotherapies. Utilizing advanced machine learning techniques, Noetik's platform identifies new therapeutic targets and designs innovative treatments. By harnessing self-supervised learning and integrating diverse human multimodal data, the company aims to enhance the precision and effectiveness of immunotherapies. This approach enables the development of more personalized cancer treatments, contributing to the advancement of targeted therapies in oncology.

DevRev

Series A in 2024
DevRev is a business software startup that focuses on bridging the gap between developers and customers by integrating development processes with customer relationship management (CRM). The company offers an artificial intelligence-native platform designed to enhance product development and customer service, enabling developers to build, support, and expand their offerings more efficiently. By adopting a product-led growth model, DevRev fosters direct collaboration and communication between developers and end-users, promoting customer-centric product development. Its unique approach allows for customizable analytics and low-latency insights, empowering companies to increase product velocity and minimize customer churn. DevRev's solutions are utilized by numerous organizations seeking to thrive in the rapidly evolving landscape of generative AI.

Planted Solar

Series A in 2024
Planted Solar develops and deploys solar power plants using a rapid deployment platform that increases energy output per acre and accelerates project delivery. It combines development software, terrain-adaptive high-density racking, and automated construction to build flexible, all-terrain power plants. Through advanced site planning and logistics, the company aims to maximize land use and streamline solar development, enabling faster, scalable deployment of clean energy.

WindBorne Systems

Venture Round in 2024
WindBorne Systems designs, builds, and operates a network of long-duration high-altitude weather balloons equipped with sensors to collect atmospheric data for weather forecasting, climate research, and environmental monitoring. The company delivers its data to government and private weather services and has developed a balloon-based sensor delivery system alongside a weather forecasting platform that provides atmospheric data collection, AI-driven forecasts, insights, alerts, evaluations, and visualizations for decision-makers. By integrating data collection with advanced forecasting tools, WindBorne Systems supports more accurate forecasts, timely warnings for severe weather, and planning for climate adaptation.

Honey Homes

Series A in 2024
Honey Homes is a home maintenance company that provides handyman, electrical, plumbing, interior and exterior maintenance services through its website and mobile applications, helping homeowners address small repair tasks and proactively maintain their homes.

Zeck

Series A in 2024
Zeck is a company that specializes in a board management platform aimed at enhancing board engagement and automating governance processes. Its application provides communication features tailored for meetings, offering customizable frameworks for organizing board sessions. The platform enables businesses to streamline their governance by automating the generation and approval of meeting minutes, facilitating secure voting, and managing document signing. Through these tools, Zeck helps organizations improve compliance and efficiency in their board management practices.

Cognition

Series A in 2024
Cognition AI is an applied AI lab focused on building end-to-end software agents that act as collaborative AI teammates. Their aim is to support engineering teams in being more efficient and innovative in their projects.

Rubedo Life Sciences

Series A in 2024
Rubedo Life Sciences, Inc. is a biopharmaceutical company based in Sunnyvale, California, focused on developing innovative therapies that target senescent cells implicated in age-related diseases. Established in 2018, the company utilizes its proprietary ALEMBIC drug discovery platform to create a pipeline of therapeutic candidates. These candidates are designed to selectively address senescent cells, as well as pro-inflammatory and pro-fibrotic cell populations that contribute to various chronic conditions, including pulmonary, dermatological, oncological, neurodegenerative, and fibrotic diseases. Rubedo's leadership team comprises industry experts with significant experience in drug development and commercialization across both large pharmaceutical companies and biotech firms.

Loft Labs

Series A in 2024
Loft Labs is a software company that enables organizations to scale self-service access to Kubernetes, from small teams to thousands of engineers. The company maintains several open-source projects, including DevSpace, vcluster, jsPolicy and kiosk, and provides a commercial platform called Loft that unifies these projects into a single Kubernetes platform. This platform gives engineers secure but unobstructed access to cloud resources, supports cloud-native engineering practices, and helps teams collaborate in shared clusters by managing access, namespaces, and user permissions.

Nabla Bio

Series A in 2024
Nabla Bio is a biotechnology company that uses artificial intelligence and lab technologies to rationally design novel proteins for drug development. They aim to create medicines and improve nutrition by engineering proteins with enhanced qualities.

Symbolica AI

Series A in 2024
Symbolica AI is a research-driven company that develops a unique business model platform. This platform leverages geometric and topological principles in machine learning to train models using formal computational logic, rather than traditional statistical methods. The result is enhanced decision-making capabilities for clients, fostering business growth.

Metaplane

Series A in 2024
Metaplane provides a data observability platform that helps organizations trust their data. It monitors modern data stacks from warehouses to BI dashboards, identifies normal behavior, and alerts teams when issues arise, saving engineering time and increasing data reliability.

Limbic

Series A in 2024
Founded in London in 2017, Limbic specializes in developing software solutions for mental health. They create AI-driven agents to assist in patient intake, triage, screening, and therapy, aiming to enhance the efficiency of healthcare providers and improve patient outcomes.

Aktiia

Series A in 2024
Aktiia develops continuous, convenient, and medical-grade blood pressure monitoring enabled by wearable sensors and machine learning. Built on extensive research, it delivers continuous BP and heart rate data to patients, researchers, and clinicians, supporting personalized insights and new understandings of hypertension. The company aims to make blood pressure management more accessible, accurate, and actionable for people worldwide, addressing a condition that affects over a billion people and causes millions of deaths annually.

Daedalus

Series A in 2024
Daedalus is a contract manufacturing company that specializes in precision parts for the CNC industry. It leverages advanced robotics and artificial intelligence to create reconfigurable production capacity, allowing for instant retooling to accommodate various manufacturing needs. The company offers a software system that enhances manufacturing efficiency and ensures high reliability and transparency throughout the production process. Daedalus is equipped to handle a wide range of production scales, from prototypes to large-scale manufacturing, thereby supporting diverse customer requirements with agility in both process and part complexity.

Recraft

Series A in 2024
Recraft is a creative AI tool.

Sun Oak Capital

Series A in 2024
Sun Oak Capital specializes in providing real estate rental services, focusing on institutionalizing vacation homes as an investment class. They offer a curated collection of family-oriented rentals, owned and operated by them, combining the comforts of home with hotel-like reliability for hassle-free vacations.

Moonwalk Biosciences

Series A in 2024
Moonwalk Biosciences is a genomic medicine startup focused on developing precision epigenetic therapeutics. The company specializes in creating a profiling and engineering technology platform that leverages advanced artificial intelligence predictions to offer a comprehensive view of the epigenome in both health and disease states. This innovative approach aims to revolutionize therapy discovery and development, enabling healthcare providers to reprogram cells back to their healthy state.

rabbit

Series A in 2023
rabbit inc. is a technology company developing consumer electronics driven by novel, simple, and intuitive interactive paradigms. rabbit is the creator of the Large Action Model (LAM), a new type of foundation model for human actions on computer applications, and rabbit OS, a personalized operating system through a natural language interface. rabbit's first product, rabbit r1, is an affordable companion device designed in collaboration with Teenage Engineering.

Encellin

Series A in 2023
Encellin Inc., established in 2016, is a biotechnology company based in San Francisco, California. It specializes in developing innovative thin-film cell encapsulation devices for cell-based therapeutics, aiming to improve the lives of patients with chronic diseases initially focusing on Type 1 diabetes. The company's technology enables encapsulated cells to function as smart molecular factories, providing potential therapeutic solutions.

Sarvam AI

Series A in 2023
Sarvam AI specializes in developing an artificial intelligence platform tailored to India's diverse linguistic landscape. The platform aims to enhance the robustness, performance, and cost-effectiveness of generative AI app development, deployment, and distribution.

Kognitos

Series A in 2023
Founded in 2021, Kognitos is a San Jose-based company specializing in AI-driven business automation. Its platform leverages natural language processing to automate complex end-to-end processes across departments like finance, HR, and operations with minimal IT involvement.

Aleph

Series A in 2023
Aleph operates a financial planning and analysis platform designed to enhance the capabilities of traditional spreadsheets such as Excel and Google Sheets. By integrating data from accounting systems and various operational sources, Aleph provides specialized financial tools that are always current. This allows clients to create sophisticated financial models and use cases, ultimately facilitating informed investment decisions. Aleph aims to support finance departments by merging the familiarity of spreadsheets with advanced financial insights, making it a valuable resource for financial professionals.

Luzia

Series A in 2023
Luzia develops AI technology for transcribing audio communications on WhatsApp. Its platform includes a chatbot accessible via WhatsApp, offering features such as answering questions, generating text, translating languages, and writing creative material to facilitate various tasks.

Mojo Vision

Series A in 2023
Founded in 2015, Mojo Vision specializes in developing and commercializing advanced micro-LED display technology for various applications. The company is renowned for creating the world's smallest dynamic display for augmented reality smart contact lenses. Headquartered in Saratoga, California, Mojo Vision aims to disrupt the $160 billion display industry with its proprietary quantum-dot technology.

CellFE

Series A in 2023
CellFE Inc. is a biotechnology company based in San Carlos, California, established in 2017. It specializes in the development of a microfluidics-based device designed to deliver gene-editing molecules into human cells. This innovative platform enhances the manufacturing and development of cell therapies by utilizing rapid cell compression techniques that facilitate the uptake of therapeutic molecules from surrounding fluids. By enabling the transport of hard-to-deliver molecules, CellFE aims to improve the effectiveness of treatments for various disorders, supporting medical researchers in their efforts to advance patient care and outcomes.

Bold

Series A in 2023
Bold is an at-home digital fitness program designed to help older adults live their strongest, happiest, and healthiest lives. As a member, you’ll enjoy instant access to expert trainers, scientific assessments, and personalized workout plans to help you improve your strength, flexibility, and balance — so you can chase the life you want, at any age.

Ello

Series A in 2023
Ello develops a reading assistance platform for early literacy that blends real books with artificial intelligence to provide each child with a personalized, phonics-based learning path. The platform delivers interactive digital and physical books, uses speech recognition to offer real-time feedback, and employs motivational strategies to sustain engagement. Grounded in evidence-based reading instruction, Ello supports children when they struggle and helps parents and educators foster confidence, fluency, and a lifelong love of reading.

Spiritus

Series A in 2023
Spiritus is a climate technology company specializing in direct-air-capture systems. Its innovative approach combines the Spiritus Sorbent and Carbon Orchard, offering a scalable, modular solution for low-cost carbon dioxide removal and sequestration.

Caelux

Series A in 2023
Caelux is a renewable energy company based in Pasadena, California, founded in 2014. It specializes in developing and manufacturing perovskite-on-glass technology for the terrestrial solar and commercial space industries. This innovative technology is designed to enhance solar device efficiency while minimizing the amount of semiconducting material required, thereby reducing production costs. Caelux's products improve power production and integrate seamlessly into existing photovoltaic module manufacturing processes, allowing users to lower installed costs and boost overall performance.

Collaborative Robotics

Series A in 2023
Collaborative Robotics is a team of innovators and builders redefining the future of human-robot interaction. A future in which robots are trustworthy extensions of the environment. They operate, adapt, and react in response.

SiPhox Health

Series A in 2023
SiPhox Health, based in Cambridge, Massachusetts, specializes in designing and manufacturing innovative diagnostic solutions. The company develops next-generation diagnostics infrastructure, including at-home test kits and central lab systems. Their flagship product is a disposable biosensor cartridge that assesses 17 blood biomarkers, providing insights into inflammation, hormonal health, metabolic fitness, and cardiovascular health. SiPhox Health's platform merges biochemistry, photonic chip technology, integrated photonics, electronics, and microfluidics to enable sensitive readouts of immunoassays and nucleic acid tests, facilitating point-of-need and at-home diagnostics.

Honey Homes

Series A in 2023
Honey Homes is a home maintenance company that provides handyman, electrical, plumbing, interior and exterior maintenance services through its website and mobile applications, helping homeowners address small repair tasks and proactively maintain their homes.

Credit Genie

Series A in 2023
Credit Genie is a fintech company that provides financial tools and debt relief services. It helps Americans take control of their finances, by offering no-fee-or-interest cash advances between paydays, tools to get out of debt, and insights into their spending habits.

Korbit Technologies

Series A in 2023
Korbit Technologies, founded in 2018 and headquartered in Montreal, Canada, specializes in developing Korbi, an artificial intelligence tutor designed to enhance the learning experience for students globally. The AI-driven platform offers interactive exercises and conversations that adapt to individual learning profiles, delivering personalized pedagogical support such as definitions, explanations, examples, and visual aids. Korbi's features include hands-on exercises, quizzes, visual diagrams, and performance tracking, all aimed at improving learning outcomes and motivation. The company serves a diverse audience, including students, teachers, publishers, and corporations, and has successfully trained nearly 20,000 learners in data science and AI. Korbit Technologies is committed to democratizing education by providing high-quality, personalized learning experiences at an accessible cost, and it has gained recognition as one of the top AI startups globally, receiving positive media coverage from prominent publications.

Gather Health

Series A in 2023
Gather Health is an international healthcare technology company dedicated to empowering chronic disease patients to enhance their health. The company develops mobile and cloud-based healthcare applications that utilize cutting-edge medical and behavioral research to motivate and educate patients. By connecting physicians, patients, their families, and communities, Gather Health aims to provide continuous and holistic care that leads to improved health outcomes. The rise in chronic diseases such as obesity, diabetes, and hypertension has created a pressing need for effective patient care solutions, especially given the shortage of healthcare providers. Gather Health's flagship product, the Gather Health Diabetes platform, is currently utilized by physicians and patients in various cities across Hong Kong and India, including Mumbai and Bangalore, demonstrating positive health outcomes for users. Headquartered in Hong Kong, with additional offices in Beijing, New York, and India, the company boasts a diverse team of clinicians, health experts, interaction designers, and engineers experienced in the global healthcare landscape.

Tachyon Therapeutics

Series A in 2023
Tachyon Therapeutics develops innovative compounds to enhance cancer treatments. It is currently conducting Phase 1 clinical trials to evaluate the safety and efficacy of its lead compound, TACH101.

Quell

Series A in 2023
Quell, Inc., founded in 2020 and based in San Francisco, California, specializes in developing an immersive fitness game that combines exercise with interactive gameplay. The company's product includes a low-cost wearable device featuring smart resistance bands, which guides users through engaging combat workouts at home. Quell's unique approach to fitness allows players to achieve their fitness goals while enjoying an intense workout within a virtual fantasy world. The startup charges a monthly fee to provide fresh content, positioning itself as a blend of Peloton and gaming experiences.

Regie.ai

Series A in 2023
Regie.ai is a technology company that specializes in AI-powered sales engagement platforms. Its flagship product, RegieOne, automates outbound prospecting tasks, enhancing workflow efficiency for operations teams. The platform integrates sales engagement, parallel dialing, data enrichment, and intent data analysis, providing users with a centralized view of their processes. Additionally, Regie.ai offers an AI content platform that creates, tests, and analyzes personalized prospecting sales campaigns, aiming to boost engagement and optimize front-line performance.

LuxWall

Venture Round in 2023
LuxWall is a building materials company that designs and manufactures vacuum-insulated glass, a transparent insulation material that reduces heating and cooling losses and improves building energy efficiency. Its vacuum-insulated glass supports energy standards for commercial and residential buildings and uses technology aimed at enabling greater thermal performance. Founded in 2020 and headquartered in Ypsilanti, Michigan, LuxWall seeks to advance sustainable construction and has indicated a potential to reduce global carbon emissions by more than 0.5 gigatonnes per year, highlighting its environmental impact.

Atmos

Series A in 2022
Atmos is a company that specializes in home-building solutions, offering a platform designed to assist customers in the creation and design of customized houses. Established in 2018 by Trent Hedge, Nicholas Donahue, Matthew Rastovac, and Austin Kahn, Atmos aims to simplify the home-building process through a managed marketplace that connects home buyers with various design options, personalized packages, and interior selections. The platform also integrates financing and construction processes, enabling customers to build their homes according to their specific preferences and financial situations.

Surge Therapeutics

Series A in 2022
SURGE Therapeutics is a biotechnology company focused on enhancing cancer treatment outcomes through innovative immunotherapy solutions. It has developed a proprietary injectable biodegradable hydrogel designed to deliver cancer therapeutics in a prolonged and localized manner. This technology enables targeted release of immunotherapy agents at the surgical site following tumor resection, allowing for more effective treatment administration. By optimizing the timing and location of drug delivery, SURGE Therapeutics aims to improve patient survival rates and minimize systemic side effects, representing a significant advancement in the field of cancer care.

Good Health Company (Clinic) (GHC)

Series A in 2022
Mars is a men's wellness brand. The company provides hair, beard, skin, performance and wellness products. Mars was established on January 31, 2021 by Samarth Sindhi in Hyderabad, Andhra Pradesh.

Ochre Bio

Series A in 2022
Ochre Bio is a biotechnology company founded in 2019 and headquartered in Oxford, United Kingdom. The firm focuses on developing genomic medicines that rejuvenate donor livers before transplantation, aiming to expand the supply of healthy organs for patients. By using genomics to identify and silence over‑active genes that drive liver disease, Ochre Bio tests novel RNA‑based therapies directly in discarded donor livers maintained on machine‑based perfusion systems. This approach allows the company to evaluate treatments in a human organ context, reducing complications such as cirrhosis and improving transplant outcomes. With more than fifteen years of liver genomics research experience, Ochre Bio leverages deep phenotyping and advanced therapeutic modalities to create a pipeline of medicines for liver and liver‑mediated conditions.

Arpeggio Bio

Series A in 2022
Arpeggio Bio, established in 2017 and headquartered in Boulder, Colorado, specializes in developing innovative software that captures snapshots of cellular RNA activity. By combining biological assays with advanced machine learning algorithms, the company enables pharmaceutical and biotechnology firms to understand a drug's mechanism of action at low sequencing depths. Arpeggio Bio's technology reveals intricate biological networks, facilitating more informed therapeutic development.

Genecis

Series A in 2022
Genecis is an early-stage organic waste processing startup that uses biotechnology to convert waste into biodegradable plastics and other high-value materials. It converts organic waste into PHA (Polyhydroxyalkanoate), a biodegradable, compostable, and non-toxic polymer that can be tuned to replace a wide variety of traditional plastics. PHA can be used for single-use plastics, clothing and textiles, automotive interiors, medical tools and products, and food contact applications.

Li Industries

Series A in 2022
Li Industries is a start-up focused on advancing lithium-ion battery recycling technologies. The company specializes in the recovery of valuable materials such as lithium, cobalt, and nickel from end-of-life batteries used in electric vehicles, consumer electronics, and other energy storage systems. By utilizing innovative direct recycling technology and a scalable electrochemical flow system, Li Industries aims to extract these essential metals efficiently and sustainably. This process not only reduces environmental waste but also supports the production of new batteries from recycled components. By optimizing the recovery and treatment of these materials, Li Industries contributes to lowering energy consumption and emissions in the battery production process, ultimately fostering a more sustainable supply chain for battery manufacturing.

Lead

Funding Round in 2022
Lead Bank is a commercial bank based in Garden City, Missouri, established in 1928. It provides a comprehensive range of banking and financial services aimed at promoting economic growth for businesses. The bank offers business accounts, cash management, credit card services, and business loans, along with online and mobile banking options. Additionally, Lead Bank specializes in transaction and financial advisory services, including interim executive placements, financial and strategic planning, mergers and acquisitions advisory, private equity placements, capital sourcing, and business valuations. Through its division, Lead Business Advisors, the bank also delivers advisory services that encompass bookkeeping and business brokerage.

Neon

Series A in 2022
Neon is a cloud-native, fully managed Postgres as a service. By separating storage from computing, Neon offers autoscaling, branching, and bottomless storage to give developers a simple, reliable, and powerful experience. Neon aims to provide a highly performant and cost-effective database infrastructure by leveraging cloud-native technologies and innovative architectural features.

Traba

Series A in 2022
Traba operates a human resource marketplace that connects industrial workers with businesses. It facilitates the filling of open shifts at warehouses, distribution centers, and event venues, empowering both parties to optimize productivity and earning potential.

Faeth Therapeutics

Series A in 2022
Faeth Therapeutics is a healthcare company dedicated to enhancing cancer treatment through a deep understanding of the relationship between dietary nutrients and tumor growth. By aligning specific diets with tumor genotypes and treatment regimens, Faeth aims to limit the energy and resources that tumors need to proliferate, thereby improving patient outcomes in cancer therapy. Founded by leading researchers and clinicians, the company seeks to translate significant discoveries from cancer research laboratories into effective clinical practices, focusing on evidence-based approaches to optimize treatment strategies for cancer patients.

CHARM Therapeutics

Series A in 2022
CHARM Therapeutics uses 3D deep learning and advanced drug discovery technologies to develop transformational medicines for diseases that are difficult to treat, aiming to enable clinicians to target undruggable disease targets with novel therapies that offer potentially life-changing efficacy.

Anagenex

Series A in 2022
Anagenex is a biotechnology company developing a novel platform for drug discovery. This platform focuses on challenging targets by combining machine learning with DNA-encoded libraries and proprietary AI models to accelerate small molecule drug discovery.

Nitricity

Venture Round in 2022
Nitricity is an energy company focused on renewable nitrogen fertilizer production with zero carbon emissions. It develops electrified, climate-smart fertilizer products and manufactures nitric acid and ammonia, which can be used separately or combined to produce ammonium nitrate fertilizer. The approach aims to bring products closer to farmers, enable timely application, reduce runoff, and maximize nitrogen delivery on a global scale.

Nomagic

Series A in 2022
Nomagic, Inc. is a technology company based in Warsaw, Poland, specializing in robotic manipulation solutions for order fulfillment in e-commerce. The company develops smart pick-and-place robotic systems that enhance efficiency, flexibility, and reliability in warehouses. By automating tedious tasks, Nomagic's solutions help reduce fulfillment costs and address labor shortages, allowing operations to scale effectively and operate around the clock. Powered by artificial intelligence, their robotic systems continuously learn and adapt to changing conditions, enabling warehouse operators to improve agility and ensure reliable delivery of goods. Nomagic's technology has been implemented in notable locations, including packing lines at Cdiscount, a leading French eCommerce platform.

Adyton PBC

Venture Round in 2022
Adyton PBC specializes in designing and developing cloud-based software solutions for reporting, data maintenance, and scheduling. The company offers products such as AKADEMIA, which provides real-time reporting and analytics along with training data recording and management, and Smart Schedule, a software designed for managing training, qualifications, and daily operations. Additionally, Adyton PBC has created the Adyton Operations Kit (AOK), a secure mobile software tailored for mission-critical tasks, particularly suited for defense and emergency response applications. Founded in 2018 and headquartered in Wilmington, Delaware, Adyton PBC serves a diverse range of industries, including defense, heavy industries, law enforcement, and emergency responders.

VitroLabs

Series A in 2022
VitroLabs specializes in 3D tissue engineering, focusing on the development of real leather using stem cell-based technologies. Founded in 2016 and based in San Jose, California, the company aims to create luxury quality lab-grown leather with a low carbon footprint, thereby reducing harm to animals.

Farther

Series A in 2022
Founded in 2019, Farther is a wealth management firm that combines expert advisors with advanced technology to deliver personalized financial advice. It caters to high-net-worth individuals, offering a data-driven approach and proprietary algorithms to manage investments tailored to clients' risk tolerance.

Primer

Series A in 2022
Primer is a San Francisco-based company that operates an online platform focused on providing customized educational experiences for students at home. Through its Primer Microschools, the company emphasizes personalized learning, allowing students to progress at their own pace while pursuing their individual interests. The platform is designed to support learners by fostering an environment conducive to personal growth and development, positioning itself as a forward-thinking educational solution for the leaders of tomorrow.

Leaft Foods

Series A in 2022
Leaft Foods focuses on reducing the environmental impact of food production by harnessing Rubisco, a plentiful plant-based protein found in green leaves. The company extracts this protein through a sustainable 'paddock to production' process, creating ingredients for sustainable and nutritious food products.

World

Funding Round in 2022
World is a technology company specializing in secure digital asset management. It operates the World App, which enables users to securely store their World ID, manage digital assets, and access various Mini Apps within a privacy-focused network.

Cor

Series A in 2022
COR helps you implement globally-proven healthy lifestyle practices, then shows you a totally new type of data about how your body responds. Optimize your lifestyle and discover the impact of different daily customs with precise, science-based self-knowledge.

&Ava

Series A in 2022
Ava is a company that specializes in live captioning technology, utilizing artificial intelligence to transcribe spoken language into text. Its innovative platform is designed to enhance accessibility for the 466 million individuals who are deaf or hard of hearing worldwide. By providing instant captions and color-coded text, Ava's application facilitates seamless communication in group conversations, allowing users to actively participate in discussions and stay informed about their surroundings. This approach not only empowers deaf and hard-of-hearing individuals but also fosters improved connections among all participants in various social settings.

Volta Labs

Series A in 2022
Volta Labs, Inc. is a biotechnology company based in Cambridge, Massachusetts, founded in 2018. The company specializes in engineering and developing innovative tools for biological automation, focusing on scalable automation solutions for genetic engineering. Its platform is designed to revolutionize genomics research by providing affordable genomic sample preparation and automation for complex biological workflows. By integrating expertise from engineering, surface chemistry, and molecular biology, Volta Labs aims to streamline sample processing and enhance the capabilities of biotech organizations in the next generation of genomic automation.

Aether Diamonds

Series A in 2022
Aether Diamonds produces the world's first and only diamonds made 100% from captured carbon. Certified B Corp. 2022 Fast Company Top 10 Most Innovative Consumer Goods Companies. 2022 "Best for the World" B Corp.

Emi Labs

Series A in 2022
Emi Labs is a technology company that develops AI-powered recruitment software to transform the hiring process for firms with high-volume openings. Its flagship AI recruitment assistant engages applicants in natural conversations to identify qualified candidates while automating screening, skills validation, interview scheduling and document collection, thereby shortening hiring cycles and boosting recruiter productivity. The platform aims to improve the candidate experience and enable scalable, personalized engagement. The company operates a remote-first model with office hubs in Buenos Aires, Mexico City, and San Francisco.

WorkWhile

Series A in 2022
Founded in 2017, WorkWhile is a technology platform that connects skilled hourly laborers with job shifts across industries such as warehousing, light industrial work, delivery services, hospitality, food production, and event management. The platform uses cognitive science and behavioral analysis to match workers' skills, schedules, and locations with suitable jobs. It offers benefits like next-day pay and sick leave credits for its workforce.

Verdagy

Series A in 2022
Verdagy specializes in innovative water electrolysis technology for large-scale green hydrogen production. Based in Moss Landing, California, the company operates laboratory and pilot plant facilities to advance its technology platform, aiming to achieve low upfront capital costs and competitive unit economics.

LEX Markets

Series A in 2022
LEX Markets Corp., established in 2018 and based in New York, operates an online platform for trading shares of individual commercial real estate assets. It facilitates both accredited and non-accredited investors to buy and sell shares, with investments starting at $250 and no lockup periods. The company specializes in taking commercial buildings public through single-asset IPOs, making it possible for a broader range of investors to access the real estate market. LEX Markets' platform is powered by Nasdaq technology, ensuring robust, low latency, and high-performance trading features.

Cellino

Series A in 2022
Cellino develops scalable, automated biomanufacturing systems for personalized cell therapies based on induced pluripotent stem cells (iPSCs). The company aims to enable potentially curative, patient-specific treatments by producing autologous iPSCs at scale and applying AI-guided, image-driven laser processing and robotics to remove unwanted cells. By integrating image-guided machine learning, single-cell laser processing, and robotics, Cellino seeks to enhance precision, efficiency, and scalability in optical bioprocessing, accelerating the development of regenerative therapies for chronic degenerative diseases such as vision loss and Parkinson's disease.

Culdesac

Series A in 2022
Culdesac Inc. is a real estate development company based in San Francisco, California, focused on creating car-free residential neighborhoods in the United States. Established in 2018, the company's first project is in Tempe, Arizona, where it aims to build the first car-free neighborhood from scratch in the country. This innovative approach prioritizes pedestrian accessibility and eco-friendly living by eliminating parking spaces for residents while providing designated areas for visitors. The neighborhood will feature essential services such as grocery stores, coffee shops, coworking spaces, and market halls, allowing residents to engage with their community directly from their doorsteps. Culdesac's vision is to reimagine urban living by putting people before cars, fostering a sustainable and vibrant lifestyle.

Azibo

Series A in 2022
Founded in 2018, Azibo is a financial services platform dedicated to streamlining rental property management. It offers solutions for rent collection, banking, lending, and insurance, aiming to improve efficiency and reduce administrative burden for small real estate owners.

Fountain Therapeutics

Series A in 2021
Founded in 2018, Fountain Therapeutics develops cellular model-based therapeutics targeting age-related diseases. It employs an AI-driven platform for identifying novel targets and potential treatments.

Mimica Automation

Series A in 2021
Mimica Automation Limited is a London-based company established in 2018 that specializes in developing software to automate repetitive tasks through machine learning. The company's primary product observes users over a period of 2-3 weeks, capturing their clicks and keystrokes to understand their workflow. This data is then processed using advanced algorithms to create a comprehensive automation map, streamlining the user's tasks. Mimica's technology aims to enhance productivity by simplifying the automation process, allowing businesses to focus on more strategic activities.

Splash

Series A in 2021
Splash develops AI-powered video games that lets anyone create and perform music to live audiences inside virtual venues.

Supplant

Series A in 2021
Supplant is a biotechnology platform working in the food sector. It develops natural food ingredients from agricultural resources to allow food manufacturers to decrease sugar, increase fiber, and boost the gut health-promoting qualities of its products.

Loop

Series A in 2021
Loop Health is a healthcare provider based in Pune, India, founded in 2018. The company offers a range of services including acute and urgent care, chronic condition management, women's health, health coaching, and preventive care. Loop Health aims to simplify the healthcare experience by connecting patients with family physicians, specialists, and hospitals, facilitating access to major medical treatments. Their team of Loop Coordinators assists patients in finding appropriate doctors, comparing treatment costs, obtaining second opinions, and managing admission procedures, thereby alleviating the stress associated with healthcare decisions. Additionally, Loop Health features a virtual medical practice that supports employees and their families, allowing them to consult with healthcare experts and medical advisors without delay, ultimately promoting better health management and cost-effectiveness.

VitroLabs

Series A in 2021
VitroLabs specializes in 3D tissue engineering, focusing on the development of real leather using stem cell-based technologies. Founded in 2016 and based in San Jose, California, the company aims to create luxury quality lab-grown leather with a low carbon footprint, thereby reducing harm to animals.

Loyal

Series A in 2021
Loyal is a biotechnology company focused on developing medicines to extend the lifespan of dogs. By creating drugs that potentially slow aging processes, they aim to delay or prevent age-related diseases such as cancer and dementia.

Vanan Online Services

Series A in 2021
Vanan Online Services is a global provider of language support services, catering to both individual and business clients. The company specializes in a wide range of services, including audio and video transcription, certified translation, closed captioning, subtitling, document typing, and legal typing. Additionally, Vanan offers audio voiceover, video animation, and video editing services.

Juno

Series A in 2021
Juno Residential, Inc. is a company focused on the development of residential apartments, incorporating innovative construction methods to provide environmentally friendly housing solutions. Based in San Francisco, California, Juno specializes in prefabricated houses, utilizing techniques that emphasize speed and efficiency. The company is committed to sustainability, employing organic and low-carbon materials, such as mass timber, in its projects. By offering modern and curated living spaces, Juno aims to address the growing demand for sustainable housing alternatives in urban environments. Founded in 2018, Juno Residential, Inc. was previously known as Lighthouse Residential, Inc.

PolyAI

Series A in 2021
PolyAI Ltd is a company that specializes in developing a conversational artificial intelligence platform aimed at enhancing human-machine voice interactions. Established in 2017 and headquartered in London, United Kingdom, with an additional office in New York, the company focuses on building enterprise voice assistants that engage in natural conversations with customers to address their needs. The platform utilizes advanced machine learning and natural language processing technologies, enabling it to understand and respond to customers effectively, regardless of the variations in their speech. Key features of PolyAI’s platform include multilingual support, dynamic flow design, and task-agnostic capabilities, allowing developers to create seamless and human-like interactions within various digital environments.

Flow Neuroscience

Series A in 2021
Flow Neuroscience, established in 2011 and based in Malmö, Sweden, specializes in developing and manufacturing a wearable device and accompanying mobile application for medication-free treatment of depression. The company's core product is a transcranial direct current stimulation (tDCS) headset that targets the left frontal lobe, an area of the brain often associated with depression. This non-invasive treatment is complemented by a personalized mobile app that encourages users to adopt healthier daily routines, such as regular exercise and sleep patterns, to help alleviate depressive symptoms. Flow Neuroscience aims to make this innovative, affordable treatment accessible to the public, challenging the dominance of pharmaceuticals in mental health care.

Connie Health

Series A in 2021
Connie Health assists older Americans in making informed decisions about their healthcare by providing medical advisory services through a technology platform paired with local Medicare experts. They help individuals optimize prescription costs, find healthcare providers, and navigate insurance plan benefits.

IgGenix

Series A in 2021
IgGenix is a biotechnology company that develops an antibody-based therapeutic platform to treat food and other severe allergies. The platform re-engineers allergen-specific IgE antibodies into IgG antibodies to suppress the allergic cascade and alleviate or prevent allergic reactions. It identifies rare human B cells expressing allergen-binding antibodies and engineers them to endow immune-modulating activities derived from the IgG antibody class. Based in South San Francisco, California, the company aims to accelerate clinical responses to life-threatening allergies.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.